Abstract Background Chronic thromboembolic pulmonary hypertension (CTEPH) is optimally treated by pulmonary thromboendarterectomy (PEA). Treatment effectiveness has been evaluated principally using single-center series. Data from the Society of Thoracic Surgeons..
Read MorePatient with Chronic Thromboembolic Pulmonary HTN undergone pulmonary endarterectomy all steps from A to Z. [gallery ids="18057,18054,18051,18048"] [playlist ids="18060"] Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center..
Read MoreAbstract OBJECTIVES Chronic thromboembolic pulmonary hypertension is the only curable form of pulmonary arterial hypertension. Pulmonary endarterectomy (PEA) has been established as the treatment of choice in these patients producing..
Read MoreAbstract Introduction: Pulmonary endarterectomy (PEA) is the most effective treatment available for chronic thromboembolic pulmonary hypertension (CTEPH). Patient selection, surgical technique and perioperative management have improved patient outcomes, which are..
Read More



